Management of cytomegalovirus infection and disease after solid-organ transplantation.

Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after solid-organ transplantation. There are 3 major consequences of CMV infection: CMV disease, including a wide range of clinical illnesses; superinfection with opportunistic pathogens; and injury to the transplanted organ, possibly enhancing chronic rejection. This article discusses the considerable progress that has been made in elucidating risk factors for CMV disease, in the rapid detection of CMV in clinical specimens, and in the use of antiviral chemotherapy and immunoglobulin to prevent and treat CMV disease after solid-organ transplantation.

[1]  R. Speich,et al.  Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation. , 1999, Transplantation.

[2]  Thomas F. Smith,et al.  Evaluation of PCR Primers for Early Diagnosis of Cytomegalovirus Infection following Liver Transplantation , 1998, Journal of Clinical Microbiology.

[3]  R. Laufs,et al.  Utility of Major Leukocyte Subpopulations for Monitoring Secondary Cytomegalovirus Infections in Renal-Allograft Recipients by PCR , 1998, Journal of Clinical Microbiology.

[4]  S. Gruber,et al.  Preemptive ganciclovir therapy in cytomegalovirus-seropositive renal transplants recipients. , 1995, Archives of surgery.

[5]  B. Griffith,et al.  A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. , 1994, American journal of respiratory and critical care medicine.

[6]  N. Jiwa,et al.  RAPID DETECTION OF HUMAN CYTOMEGALOVIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTE OF VIREMIC TRANSPLANTS BY THE POLYMERASE CHAIN REACTION , 1989 .

[7]  R. Venuto,et al.  Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. , 1997, Journal of the American Society of Nephrology : JASN.

[8]  L. van Es,et al.  THE POLYMERASE CHAIN REACTION, A SENSITIVE AND RAPID TECHNIQUE FOR DETECTING CYTOMEGALOVIRUS INFECTION AFTER RENAL TRANSPLANTATION , 1992, Transplantation.

[9]  M. Harmsen,et al.  The cytomegalovirus antigenemia assay: a plea for standardization. , 1995, Scandinavian journal of infectious diseases. Supplementum.

[10]  J. Griffith,et al.  Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group. , 1997, Clinical transplantation.

[11]  S. Hammer,et al.  Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation , 1993, Annals of Internal Medicine.

[12]  T. Kawai,et al.  Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. , 1997, Transplantation.

[13]  M. Hirsch,et al.  Glomerulopathy associated with cytomegalovirus viremia in renal allografts. , 1981, The New England journal of medicine.

[14]  J. Jeekel,et al.  Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection. , 1989, Transplantation.

[15]  A. Woodcock,et al.  Preemptive treatment for the prevention of cytomegalovirus disease: in lung and heart transplant recipients. , 1998, Transplantation.

[16]  P. Griffiths,et al.  RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCI , 1984, The Lancet.

[17]  T. Merigan,et al.  A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.

[18]  S. Larsson,et al.  Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time , 1998, Transfusion.

[19]  C. Crumpacker,et al.  Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. , 1995, The Journal of infectious diseases.

[20]  P. Griffiths,et al.  Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation , 1997, Journal of medical virology.

[21]  K. Yuen,et al.  Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. , 1997, Clinical transplantation.

[22]  S. Spector,et al.  EARLY DIAGNOSIS OF HUMAN CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS BY DNA AMPLIFICATION IN PLASMA , 1993, Transplantation.

[23]  P. Griffiths,et al.  Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. , 1995, The Journal of general virology.

[24]  M. Pescovitz,et al.  Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients , 1997, The Lancet.

[25]  N. Ahsan,et al.  Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients. , 1997, Clinical transplantation.

[26]  S. Pauker,et al.  Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis. , 1991, Transplantation.

[27]  W. Siegert,et al.  COMPARISON OF POLYMERASE CHAIN REACTION FROM PLASMA AND BUFFY COAT WITH ANTIGEN DETECTION AND OCCURRENCE OF IMMUNOGLOBULIN M FOR THE DEMONSTRATION OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION , 1995, Transplantation.

[28]  M. Schnitzler,et al.  Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. , 1997, Transplantation.

[29]  A. Gaeta,et al.  Monitoring for cytomegalovirus infection in organ transplant recipients: Analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes , 1997, Journal of medical virology.

[30]  D. Pillay,et al.  PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS , 1993, Transplantation.

[31]  G. Tufveson,et al.  A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival. , 1996, Clinical transplantation.

[32]  C. Pouteil‐Noble,et al.  Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis. , 1998, Transplantation.

[33]  Jaap M Middeldorp,et al.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay , 1984, Journal of clinical microbiology.

[34]  M. van der Giessen,et al.  Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. , 1989, Transplantation.

[35]  A. Bitsch,et al.  A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients , 1993, Transplant international : official journal of the European Society for Organ Transplantation.

[36]  W. V. van Son,et al.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes , 1988, Journal of medical virology.

[37]  P. Griffiths,et al.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. , 1982, Journal of clinical pathology.

[38]  D. Snydman,et al.  Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients , 1995, Annals of Internal Medicine.

[39]  R. Rubin,et al.  Infection in organ-transplant recipients. , 1998, The New England journal of medicine.

[40]  H. Friedman,et al.  Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. , 1991, Annals of internal medicine.

[41]  C. Ronalds,et al.  Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products. , 1985, Journal of clinical pathology.